摘要
Abstract
Objective To discuss the clinical effect of sibelium combined with ligustrazine on vertebral-basilar ischemic vertigo(VBIV), and to provide scientific direction for drug application. Methods 136 cases of VBIV patients who were admitted into our hospital were retrospectively analyzed and were divided into sibelium group(68 cases) and combined treating group(68 cases) on the basis of respecting personal willingness.The sibelium group was treated with sibelium capsule 10mg at a time/d,the treatment course was 14 d,while the combined treating group was treated with ligustrazine injection 200mg at a time/d by intravenous drip.The clinical effect and safety of two methods were comparatively analyzed. Results The total clinical effect of combined treating group reached to 91.17%,and was obviously higher than sibelium group(P < 0.05).Meanwhile,the safety value of combined treating group reached to 97.06%,and was superior to sibelium group (P < 0.05).Conclusion As a combined treating method,sibelium combined with ligustrazine has a good effect on VBIV clinical therapy,it worth to be vigorously promoted in clinical treatment.关键词
西比灵/川芎嗪/椎-基底动脉供血不足/眩晕/临床疗效Key words
Sibelium/Ligustrazine/Vertebral-basilar ischemia/Vertigo/Clinical effect分类
医药卫生
